Published • loading... • Updated
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
Summary by Financial Post
3 Articles
3 Articles
The Record+2 Reposted by 2 other sources
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
New method of use patent covering pelareorep as an immunotherapy for cancer has been issued in several countries, with U.S. issuance expected in the near term
·Woodland Park, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left2Leaning Right1Center0Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
